The results offer us a comprehensive understanding of the therapeutic effects of previously identified target proteins, including AKT1, IL6, PPARG, JUN, CASP3, EGFR, and PTGS2, in the context of diabetes intervention. The gene discussed is JUN; the disease is diabetes mellitus.